Abstract:Balanced general anesthesia, the most common management strategy used in anesthesia care, entails the administration of different drugs together to create the anesthetic state. Anesthesiologists developed this approach to avoid sole reliance on ether for general anesthesia maintenance. Balanced general anesthesia uses less of each drug than if the drug were administered alone, thereby increasing the likelihood of its desired effects and reducing the likelihood of its side effects. To manage nociception intraoperatively and pain postoperatively, the current practice of balanced general anesthesia relies almost exclusively on opioids. While opioids are the most effective antinociceptive agents, they have undesirable side effects. Moreover, overreliance on opioids has contributed to the opioid epidemic in the United States. Spurred by concern of opioid overuse, balanced general anesthesia strategies are now using more agents to create the anesthetic state. Under these approaches, called "multimodal general anesthesia," the additional drugs may include agents with specific central nervous system targets such as dexmedetomidine and ones with less specific targets, such as magnesium. It is postulated that use of more agents at smaller doses further maximizes desired effects while minimizing side effects. Although this approach appears to maximize the benefit-to-side effect ratio, no rational strategy has been provided for choosing the drug combinations. Nociception induced by surgery is the primary reason for placing a patient in a state of general anesthesia. Hence, any rational strategy should focus on nociception control intraoperatively and pain control postoperatively. In this Special Article, we review the anatomy and physiology of the nociceptive and arousal circuits, and the mechanisms through which commonly used anesthetics and anesthetic adjuncts act in these systems. We propose a rational strategy for multimodal general anesthesia predicated on choosing a combination of agents that act at different targets in the nociceptive system to control nociception intraoperatively and pain postoperatively. Because these agents also decrease arousal, the doses of hypnotics and/or inhaled ethers needed to control unconsciousness are reduced. Effective use of this strategy requires simultaneous monitoring of antinociception and level of unconsciousness. We illustrate the application of this strategy by summarizing anesthetic management for 4 representative surgeries.

Multimodal therapy in perioperative analgesia

Multimodal Analgesia, Current Concepts, and Acute Pain Considerations

The Role of Multimodal Analgesia in Spine Surgery

Rational Multimodal Analgesia for Perioperative Pain Management

Designing the ideal perioperative pain management plan starts with multimodal analgesia

Multimodal analgesia in neurosurgery: a narrative review

Multimodal General Anesthesia: Theory and Practice

Multimodal Analgesia Techniques and Postoperative Rehabilitation

Non-Opioid Perioperative Pain Strategies for the Clinician: A Narrative Review

Integrating complementary medicine in the perioperative period: a simple, opioid-sparing addition to your multimodal analgesia strategy?

Multimodal Analgesia in the Aesthetic Plastic Surgery: Concepts and Strategies

New modalities of pain treatment after outpatient orthopaedic surgery

Postoperative Multimodal Analgesia in Cardiac Surgery

Perioperative multimode analgesia in orthopedic surgery

Recent Advances in Multimodal Analgesia

[A multimodal and multidisciplinary postoperative pain management concept]

Multimodal analgesia versus traditional opiate based analgesia after cardiac surgery, a randomized controlled trial

Multimodal pain management after total joint arthroplasty

Current evidence of multimodal anesthesia on postoperative outcomes (Web of Science).

Multimodal analgesia as an essential part of enhanced recovery protocols in the ambulatory settings